Navigation Links
OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Date:11/15/2012

SAN DIEGO, Nov. 15, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, announces positive preliminary results from a Phase II trial investigating the use of ImmunoPulse in metastatic melanoma patients at the 6th World Meeting of Interdisciplinary Melanoma Skin Cancer Centres & 8th EADO Congress. This preliminary interim analysis of 13 out of 25 patients supports key findings from a Phase I trial suggesting that ImmunoPulse is able to induce regression or stabilization of distant untreated metastases following a single cycle of treatment.

(Logo:  http://photos.prnewswire.com/prnh/20120905/LA68078LOGO)   

A total of up to 25 patients with stage III or IV cutaneous and in-transit metastatic melanoma will be enrolled in this Phase II, single-arm, open-label and multi-center study. The trial was designed to assess local and distant objective response following treatment of cutaneous melanoma lesions with ImmunoPulse. As per the protocol, a preliminary interim analysis was scheduled upon completion of 50 percent enrollment in the study.

The purpose of the analysis was to confirm safety and efficacy observed in the Phase I study. At the time of this preliminary interim analysis, 13 patients were enrolled and treated. Thirteen subjects were evaluable at Day 39, nine at Day 90, and two at Day 180. Ninety-five percent of treated lesions demonstrated response at Day 39 (5 percent progressive disease, 14 percent stable disease (SD), 42 percent partial response (PR), 39 percent complete response (CR)). All treated lesions at Day 90 (5 percent SD, 50 percent PR, 45 percent CR), and at Day 180 (33 percent PR, 67 percent CR) demonstrated a response. At Day 180, two subjects were evaluable for the primary endpoint of objective overall respons
'/>"/>

SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
2. OncoSec to Present at Upcoming Healthcare and Investor Conferences
3. OncoSec Granted New Patent from China
4. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
5. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
6. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
7. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
8. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
9. OncoSec Medical Issues Letter to Shareholders
10. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
11. Patient and Disability Groups Support Bill to Begin Market Pricing System for Home Medical Equipment in Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014 Cynosure, Inc. ... light-based aesthetic treatments for non-invasive and minimally invasive applications, today ... President, Chief Operating Officer and Chief Financial Officer Timothy ... 1, 2014.  Baker, 53, will continue to serve as CFO ... Davin , who remains Chairman and Chief Executive Officer. ...
(Date:7/30/2014)... 30, 2014  Packaging Coordinators, Inc. (PCI) is pleased ... acquire Penn Pharmaceutical Services Limited (Penn Pharma). Penn Pharma is ... the United Kingdom and operates ... and Tokyo , Japan. Penn Pharma ... and Commercial dosage form manufacturing, as well as Clinical ...
(Date:7/30/2014)... , July 30, 2014   Medical Equipment ... have been awarded a Department of Defense (US Army) ... to supply a mobile MRI diagnostic machine and technical ... Business (WOSB) through the Small Business Administration (SBA), Medical ... the field with the latest medical diagnostic equipment. The ...
Breaking Medicine Technology:Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... Reportlinker.com announces that a new market research ... Global Computer Assisted Surgical (CAS) Systems ... This report analyzes the worldwide markets ... Million by the following Product Segments: Surgical Planners ...
... YORK, Feb. 24, 2011 Reportlinker.com announces that a ... Global Drug-Eluting Stents Industry ... report analyzes the worldwide markets for Drug-Eluting Stents in ... the US, Japan, Europe, and Rest of World. Annual ...
Cached Medicine Technology:Reportlinker Adds Global Computer Assisted Surgical (CAS) Systems Industry 2Reportlinker Adds Global Drug-Eluting Stents Industry 2
(Date:7/30/2014)... Ann Arbor, MI, July 31, 2014 Regardless of ... were more likely to develop a drinking problem if ... problems, divorce, and serious financial and legal problems ... by researchers at Columbia University,s Mailman School of Public ... of Preventive Medicine . , Alcohol abuse is a ...
(Date:7/30/2014)... July 31, 2014 “United States Orthopedic Braces ... on the United States Orthopedic Braces and Supports market. The ... (in units) and average price data (in US dollars), within ... , Ankle Braces and Supports , ... and Supports. , Orthotics is a specialty within ...
(Date:7/30/2014)... Daily Gossip mentions that the "Panic Away" ... way to stop anxiety and eliminate all associated symptoms. It ... less than 150,000 people in getting their lives back. , ... anxiety treatment system that will teach sufferers different techniques on ... very simple to access, as it is available in a ...
(Date:7/30/2014)... Ticket Down is a reputable source for ... friendly exhibition match at the Red Bull Arena in ... that was left standing as the best team in the ... largest football competition and even embarrassed the host nation Brazilian ... Germany was led by seven players that called Bayern Munich ...
(Date:7/30/2014)... in sub-Saharan Africa is being revitalized and expanded ... enrollment, broadening curricula, upgrading Internet access and providing ... In the first substantial publication by participants of ... more than 225 authors detailed progress being made ... a supplement being published today by the journal ...
Breaking Medicine News(10 mins):Health News:Veterans' alcohol problems linked to stress on the home front 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 3Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 4Health News:Panic Away Review Reveals How to Stop Anxiety 2Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 2Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 3Health News:Journal supplement details progress in African medical education 2Health News:Journal supplement details progress in African medical education 3
... on added benefits to improve care and quality ... health conditions -, ATLANTA, Oct. 27 ... which begins November 15th, Care,Improvement Plus today announced ... offerings for chronically ill Medicare beneficiaries in Georgia,including ...
... a Federal Office of Men,s Health, WASHINGTON, Oct. ... effort, was administered to the Secretary/ Director,of 50 State ... Office, where appropriate. The survey findings were,presented at the ... October 26th, 2008 and are available at MHN,s booth ...
... WellPoint Institute of Health Care Knowledge Releases Study on the ... ... According to a study released by,the WellPoint Institute of Health ... cost savings,for employers. This second study released by the Institute, ...
... health-care providers may advise their patients to quit smoking, ... their patients through the cessation process. New research presented ... of the American College of Chest Physicians (ACCP), shows ... receive less than 5 hours of training on tobacco ...
... of food and water,contamination, BELLEVILLE, ON, ... (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical company, ... designed to reduce the shedding by cattle ... full licensing approval from the Canadian,Food Inspection ...
... Oct. 27 FGX International,Holdings Limited (Nasdaq: FGXI ... fiscal 2008 financial results after the market closes on,Wednesday, ... call on,Thursday, November 13, 2008 at 8:30 AM EST, ... Financial Officer and Jack Flynn,President to discuss its latest ...
Cached Medicine News:Health News:Care Improvement Plus Launches 2009 Benefits in Georgia 2Health News:New State Public Health Department Survey Results Highlight Available Resources for Men and Women 2Health News:Research Shows Consumer-Directed Health Plans Encourage Preventive Care 2Health News:Research Shows Consumer-Directed Health Plans Encourage Preventive Care 3Health News:Physicians lack smoking cessation training 2Health News:Physicians lack smoking cessation training 3Health News:World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada 2Health News:World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada 3Health News:World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada 4Health News:World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada 5Health News:World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada 6Health News:FGX International to Release Third Quarter Earnings 2
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... operate in a wide variety of applications. • ... manifold can be freely rotated against the handle ... at an optimum angle towards the microtiter plate. ... use of most common pipette tips, and provides ...
Pipetman 8X200 Multichannel Pipette is an eight-channel, fully adjustable, air-displacement pipette having a useful volume range from 20 L to 200 L. Robustwith the usual Gilson qualities this pipette...
... Finnpipette Focus multichannel ... dispensing of reagents into ... for 0.1-10 l volumes. ... of Finnpipette Focus multichannels, ...
Medicine Products: